Skip to Content
Find More Like This
Return to Search

Use of anti-glaucoma drugs to treat visual defects associated with the use of a GABAergic agent

United States Patent Application

20040242457
A1
View the Complete Application at the US Patent & Trademark Office
Brookhaven National Laboratory - Visit the Office of Technology Commercialization and Partnerships Website
The invention provides a method for treating visual field defects associated with the use of GABAergic drugs in a mammal in need thereof. The method comprises administering an effective amount of a drug that improves retinal perfusion. Novel compositions containing a GABAergic drug and a drug that improves retinal perfusion are also provided.
Ashby, Charles R. JR. (Sound Beach, NY)
10/ 446,285
May 27, 2003
[0001] This invention was made with Government support under contract number DE-AC02-98CH10886, awarded by the U.S. Department of Energy. The Government has certain rights in the invention.